1,3-ditolylguanidine has been researched along with Ischemic Attack, Transient in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lipton, P; Lobner, D | 2 |
2 other study(ies) available for 1,3-ditolylguanidine and Ischemic Attack, Transient
| Article | Year |
|---|---|
Intracellular calcium levels and calcium fluxes in the CA1 region of the rat hippocampal slice during in vitro ischemia: relationship to electrophysiological cell damage.
Topics: Amiloride; Animals; Calcium; Dizocilpine Maleate; Ethers, Cyclic; Guanidines; Hippocampus; In Vitro Techniques; Ischemic Attack, Transient; Kinetics; Male; Microscopy, Electron; Okadaic Acid; Pyramidal Tracts; Quinoxalines; Rats; Rats, Sprague-Dawley; Time Factors | 1993 |
Sigma-ligands and non-competitive NMDA antagonists inhibit glutamate release during cerebral ischemia.
Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Animals; Anticonvulsants; Cyclazocine; Dizocilpine Maleate; Glutamates; Guanidines; Haloperidol; Hippocampus; In Vitro Techniques; Ischemic Attack, Transient; Ketamine; Kynurenic Acid; Male; Models, Neurological; Phencyclidine; Pyramidal Tracts; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid; Receptors, sigma | 1990 |